Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
53 participants
INTERVENTIONAL
2019-06-11
2020-11-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Phenotype-Tailored Lifestyle Intervention for Obesity: A Randomized Trial
NCT06770049
LIFT: Lifestyle Interventions For Two
NCT01616147
Enhancing Physical Activity and Weight Reduction Through Smartcare and Financial Incentives
NCT02548182
Lifestyle Intervention for Healthy Change
NCT05956574
The Effect of Lifestyle Treatment in Patients With Morbid Obesity
NCT03593148
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Disclosure of obesity-related genetic risk with tailored lifestyle recommendations
Participants received their obesity-related genetic test results, including variants in FTO (rs9939609), MC4R (rs17782313), and BDNF (rs6265), along with genotype-tailored lifestyle recommendations. The counseling materials encouraged risk-allele carriers to adopt healthier behaviors such as reducing fat intake, limiting snacking, and avoiding emotional eating. Personalized genetic results and recommendations were delivered at baseline through a user-friendly report.
Obesity-related genetic information disclosure with tailored lifestyle recommendations
They received their complete SNP results, including obesity-related traits, along with corresponding lifestyle recommendations.
Disclosure of non-obesity-related genetic traits only
Participants received genetic test results limited to non-obesity-related traits (e.g., beauty-related genes). They did not receive any obesity- or metabolism-related genetic information or tailored lifestyle recommendations. The full obesity-related genetic results were disclosed only after completion of the final follow-up.
Non-obesity-related genetic information disclosure
Provided only with genetic test results related to beauty traits at baseline; information on metabolic health-related SNPs was disclosed only after the final follow-up assessment.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Obesity-related genetic information disclosure with tailored lifestyle recommendations
They received their complete SNP results, including obesity-related traits, along with corresponding lifestyle recommendations.
Non-obesity-related genetic information disclosure
Provided only with genetic test results related to beauty traits at baseline; information on metabolic health-related SNPs was disclosed only after the final follow-up assessment.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Individuals who are able and willing to participate consistently for the entire 2-year study period.
Exclusion Criteria
2. Individuals currently taking long-term prescribed medications.
3. Individuals diagnosed with eating disorders or mental illnesses (e.g., depression, panic disorder) by a physician.
4. Individuals who have undergone gastric surgery for weight loss.
5. Individuals who have undergone heart surgery or cancer surgery.
6. Individuals with severe anemia.
7. Individuals who are unable to engage in physical exercise.
8. Pregnant or breastfeeding women, or those planning to become pregnant within 2 years.
18 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NaNa Keum
OTHER
National Research Foundation of Korea
OTHER
DongGuk University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
NaNa Keum
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
NaNa Keum, ScD
Role: PRINCIPAL_INVESTIGATOR
DongGuk University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dongguk University
Goyang-si, Gyeonggi-do, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-12-006
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.